Fatima N Hitawala on Muck Rack

Fatima N Hitawala

Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Fatima N

Contact Fatima N, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

What has AlphaFold3 learned about antibody and nanobody docking, and what remains unsolved?

|
By Jeffrey Gray, Johns Hopkins, Fatima N Hitawala
| biorxiv.org
Abstract Antibody therapeutic development is a major focus in healthcare. To accelerate drug development, significant efforts have been directed towards the in silico design and screening of antibodies for which high modeling accuracy is necessary. To probe AlphaFold3's (AF3) capabilities and limitations, we tested AF3's ability to capture the fine details and interplay between antibody structure prediction and antigen docking accuracy.
Open in Who Shared Issue with article?
See all 1 articles
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified